HK's Immuno Cure nabs $12m in first close of Series A led by

It will use the proceeds to develop its DNA vaccines and antibodies and prepare for an initial public offering (IPO) in Hong Kong.

Related Keywords

Hong Kong , , Alibaba Hong Kong Entrepreneurs Fund , Greater Bay Area Fund , Technology Parks Corporation , Hong Kong Based , Immuno Cure Biotech , Gobi Partners , Bay Area Fund , Alibaba Hong Kong Entrepreneurs , Greater Bay Area , Animoca Brands , Hong Kong Science , Shanghai Teresa Healthcare ,